IVEMSA Welcomes Furukawa Electric Group to Mexicali During Ribbon-Cutting

IVEMSA Welcomes Furukawa Electric Group to Mexicali During Ribbon-Cutting

Furukawa LatAm Opens 6,000-square meter facility, brings jobs to Mexico with IVEMSA’s guidance

PR Newswire

MEXICALI, Mexico, Dec. 15, 2017 /PRNewswire/ – Furukawa Electric LatAm, with the guidance of Mexico manufacturing consultants IVEMSA, opened its new 6,000-square meter manufacturing facility in Mexicali last Friday, December 8. Furukawa LatAm, a Furukawa Electric Group company that produces products and equipment for indoor and outdoor network infrastructure solutions, worked closely with IVEMSA to select the facility and set up their business entity in Mexico.

IVEMSA president Sergio Tagliapietra attended the new facility’s ribbon-cutting as an honored guest and joined mayor of Mexicali, Gustavo Sanchez, and Furukawa Electric executives at the presidium. Mayor Sanchez welcomed Furukawa Electric to Mexicali and thanked IVEMSA for their continuing efforts to bring more foreign businesses to Mexicali and Mexico. He also recognized IVEMSA’s long history of supporting foreign companies through shelter services and its benefits for Mexicali’s economic development.

The new facility will have two operating units: one to produce fiber optic cables and cordages, and the other to connect and assemble optical equipment, cordages and accessories. Furukawa Electric expects to generate 150 direct and 30 indirect jobs through the new plant in just the first year.

Furukawa selected IVEMSA to guide them throughout the project, a process that took about two years and included numerous visits to Mexicali. IVEMSA advised the company on site selection, helped them navigate the city and explained best-case scenarios for setting up in Mexico. IVEMSA also provided guidance on fiscal, trade compliance and environmental regulations. 

Roberto Durazo, Director of Business Development for IVEMSA said, “We are very proud to support the new Furukawa Electric operations with our hands-on management services. We are offering all our support for ongoing project management, recruiting, HR compliance, trade compliance, logistics coordination, accounting and finance services.”   

Founded in 1982, IVEMSA provides shelter and administrative services to foreign companies that want to move manufacturing operations to Mexico. Based in Mexicali and with six locations throughout Baja and Central Mexico, IVEMSA guides companies through the entire process of establishing and conducting operations in Mexico, including site selection, trade compliance, human resources, recruiting, accounting and environmental health and safety.

For more information on IVEMSA, visit ivemsa.com.

For more information on Furukawa Electric LatAm, visit furukawalatam.com


Cision View original content:http://www.prnewswire.com/news-releases/ivemsa-welcomes-furukawa-electric-group-to-mexicali-during-ribbon-cutting-300572095.html


Aerion and Lockheed Martin Join Forces to Develop World’s First Supersonic Business Jet


Aerion and Lockheed Martin Join Forces to Develop World’s First Supersonic Business Jet

PR Newswire

WASHINGTON, Dec. 15, 2017 /PRNewswire/ — Two leaders in supersonic technology, Aerion and Lockheed Martin (NYSE: LMT) announced a Memorandum of Understanding (MOU) today to define a formal and gated process to explore the feasibility of a joint development of the world’s first supersonic business jet, the Aerion AS2. Over the next 12 months, the companies will work together to develop a framework on all phases of the program, including engineering, certification and production.

AS2 design advances with new engine configuration. Aerion has refined the aircraft design.
Previously, three engines were grouped in the rear. The refined configuration still incorporates 3 engines, however the two outboard engines are now pulled forward, under the wing, while the 3rd remains in the tail. This configuration with 18,000-pound thrust turbofan engines, improves weight, balance, systems layout, maintainability, and simplifies some certification requirements.

Aerion Chairman Robert M. Bass stated, “This relationship is absolutely key to creating a supersonic renaissance. When it comes to supersonic know-how, Lockheed Martin’s capabilities are well known, and, in fact, legendary. We share with Lockheed Martin a commitment to the long-term development of efficient civil supersonic aircraft.”

“We are excited to work with Aerion on their development of the next-generation, efficient supersonic jet that will potentially serve as a platform for pioneering future supersonic aircraft,” said Orlando Carvalho, Executive Vice President, Lockheed Martin Aeronautics.

The MOU is the result of extensive discussions between Aerion and Lockheed Martin’s Skunk Works® Advanced Development Programs team. For close to 75 years, Skunk Works has existed to create revolutionary aircraft that push the boundaries of what is possible.

Lockheed Martin, known for developing the world’s leading supersonic combat aircraft, the F-16, the F-35, and F-22, as well as the Mach 3+ SR-71 reconnaissance aircraft, is committed to fostering new innovations and developing supersonic technologies with civil and commercial applications.

“Following our initial review of Aerion’s aerodynamic technology, our conclusion is that the Aerion AS2 concept warrants the further investment of our time and resources,” said Carvalho. “We are committed to remaining on the cutting edge of aerospace technology and are excited to examine the contribution we might make to working with Aerion on making aviation history.”

During the last two and a half years, Aerion advanced the aerodynamics and structural design of the AS2 through a previous engineering collaboration agreement with Airbus. Through that effort, the two companies developed a preliminary design of wing and airframe structures, systems layout, and preliminary concepts for a fly-by-wire flight control system.

“We are grateful for Airbus’ contribution to the program,” said Brian Barents, Aerion Executive Chairman. “We could not have moved the program to this stage without their support.”

In May 2017, GE Aviation announced an agreement with Aerion to define a supersonic engine for the AS2. The latest announcement with Lockheed Martin further positions Aerion as the leader in the nascent sector of civil supersonic aviation.

About Aerion Corporation

Aerion Corporation of Reno, Nevada, was formed in 2003 to introduce a new era of practical and efficient supersonic flight. Over more than a decade, Aerion has developed and demonstrated advanced wing technology in conjunction with NASA and other leading aeronautical institutions. This research includes breakthrough work in supersonic natural laminar flow, the key enabling technology behind the AS2 business jet.

The 12-passenger AS2 is expected to fly at a maximum speed of Mach 1.4 over water, and, where permitted by regulation, at speeds approaching Mach 1.2 without a sonic boom reaching the ground. Thanks to its unique supersonic natural laminar flow wing, the aircraft is expected to achieve long range (LA to Paris) and efficiency at supersonic and subsonic speeds. Once fielded, it will reduce trans-Atlantic trips by as much as three hours, enabling business leaders to fly roundtrip between New York and London in a day.

In November 2015, Aerion announced a fleet order from fractional aircraft fleet operator Flexjet for 20 AS2 aircraft. Aerion expects the AS2’s first flight in 2023 and certification in 2025.

About Lockheed Martin

Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 97,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration, and sustainment of advanced technology systems, products, and services.

More information can be found at www.aerionsupersonic.com.

B-roll available at https://www.dropbox.com/s/rtl7b3xwwe9aukl/AERION_AS2_PRESS_B-ROLL_171212rev.mp4?dl=0.

Statements in this release about future actions and the consequences of these actions or not otherwise statements of historical fact are “forward-looking statements” and, to the extent attributable to Lockheed Martin, are based on Lockheed Martin’s current expectations and assumptions. Forward-looking statements in this release include, but are not limited to, the potential that Lockheed Martin will enter into a binding commitment with Aerion, the nature and scope of any such commitment, Aerion’s technology and the prospects of the AS2 program. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by the forward-looking statements.


AS2 interior carries 12 in large-business-jet comfort up to 5,400 nautical miles (6,215 statute miles/10,000 km). Max. cruise speed is Mach 1.4, about 55 percent faster than today’s fastest commercial jets, at a speed greater than 1,000 mph/1,600 kph. The AS2 saves as much as three hours across the Atlantic and more than five hours across the Pacific. Aerion is working with Lockheed Martin and GE Aviation to develop the AS2.

Lockheed Martin Logo (PRNewsFoto/Lockheed Martin)

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/aerion-and-lockheed-martin-join-forces-to-develop-worlds-first-supersonic-business-jet-300571796.html

SOURCE Lockheed Martin Aeronautics Company

MYM Submits Confirmation of Readiness for a License Under the ACMPR to Health Canada for Laval, Quebec Facility

MYM Submits Confirmation of Readiness for a License Under the ACMPR to Health Canada for Laval, Quebec Facility

Canada NewsWire

VANCOUVER, British Columbia, Dec. 15, 2017 /CNW/ – MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) (the “Company” or “MYM”) is pleased to announce it has submitted the Confirmation of Readiness for a License under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to Health Canada for the Sublime production facility in Laval, Quebec.

The Laval Facility – phase one of the Laval facility is 10,000 sf. Phase two, scheduled to be completed in 2018, will see the growing area expanded to 37,000 sf. This license will enable MYM to manufacture its branded medicinal THC and CBD products. The Laval project is estimated to produce gross sales of $27 million by 2019 with profit estimates of $17 million, based on current per gram prices of $8.50.

“We are delighted to have met our stated target deadline of December 15 for the submission of the Confirmation of Readiness for a License,” said Rob Gietl, MYM CEO. “This submission is a key milestone for MYM and its partners, one of many more to come. We are looking forward to beginning production at the Laval facility and are committed to continuing to build value for the Province of Quebec and our shareholders.”

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products.  MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

Rob Gietl, CEO
MYM Nutraceuticals Inc. 

Keep up to date with MYM on our social media channels:
Twitter: @MYM_Nutra
Facebook: @mymcanada
Instagram: @MYM_Nutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States“, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Investor Relations
Terry Brown

Cision View original content:http://www.prnewswire.com/news-releases/mym-submits-confirmation-of-readiness-for-a-license-under-the-acmpr-to-health-canada-for-laval-quebec-facility-300571944.html

SOURCE MYM Nutraceuticals Inc.

View original content: http://www.newswire.ca/en/releases/archive/December2017/15/c4168.html